Magenta Therapeutics Inc.

NASDAQ: MGTA · Real-Time Price · USD
0.70
-0.06 (-7.69%)
At close: Sep 11, 2023, 10:00 PM

Magenta Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
22.79M 57.63M 131.65M
Short-Term Investments
252.45M 54.41M 45.28M
Long-Term Investments
81.73M n/a n/a
Other Long-Term Assets
9.63M 1.78M 5.55M
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
5.66M 3.56M 3.77M
Total Current Assets
280.9M 115.6M 176.93M
Property-Plant & Equipment
1.75M 29.26M 7.46M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
93.1M 31.04M 13.01M
Total Assets
374.01M 146.65M 189.93M
Account Payables
4.58M 2.45M 3.04M
Deferred Revenue
479K n/a n/a
Short-Term Debt
320K 3.82M n/a
Other Current Liabilities
13.07M 8.27M 7.82M
Total Current Liabilities
18.45M 14.55M 10.86M
Long-Term Debt
1.17M 26.14M n/a
Other Long-Term Liabilities
1.91M n/a 6.4M
Total Long-Term Liabilities
3.08M 26.14M 6.4M
Total Liabilities
21.53M 40.69M 17.26M
Total Debt
1.49M 29.96M n/a
Common Stock
31K 61K 59K
Retained Earnings
-174.39M -402.03M -325.57M
Comprehensive Income
106K -181K -30K
Shareholders Equity
352.48M 105.96M 172.67M
Total Investments
334.18M 54.41M 45.28M